Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis (scientific article published in October 2009)

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease

Q43614603

Statins as potent antiinflammatory drugs

Q44179182

Early-onset carotid atherosclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers

Q44269122

Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes

Q44283353

High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study

Q44585429

Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus

Q44786820

Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation

Q44877647

Direct demonstration of an antiinflammatory effect of simvastatin in subjects with the metabolic syndrome

Q46136981

Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study

Q46481435

Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition

Q57420160

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

Q28186001

Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications

Q28469007

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

Q29012156

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Q29547752

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

Q29616284

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

Q33942737

High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications

Q35652755

The effects of statin therapy on plasma markers of inflammation in patients without vascular disease.

Q36065857

Secondary prevention of cardiovascular disease in type 2 diabetes and prediabetes: a cardiologist's perspective

Q37013149

Targeting cardiovascular risk in patients with diabetes: management of dyslipidemia

Q37100803

SAA, an apoprotein of HDL: its structure and function

Q40333583

Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

Q40530895

Regulation of the human acute phase serum amyloid A genes by tumour necrosis factor-alpha, interleukin-6 and glucocorticoids in hepatic and epithelial cell lines

Q40590954

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

Q40828366

A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil

Q42483771

Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity

Q42811622

Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients

Q43542961

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

inflammation

simvastatin

atherosclerosis

page(s)

262-268

P577

publication date

2009-10-01

P1433

published in

Diabetes and Vascular Disease Research

Q5270121

P1476

title

Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis

P478

volume

Reverse relations

cites work (P2860)

Q51031273	A novel synthetic mono-carbonyl analogue of curcumin, A13, exhibits anti-inflammatory effects in vivo by inhibition of inflammatory mediators.
Q64945853	Adiponectin, Obesity, and Cancer: Clash of the Bigwigs in Health and Disease.
Q85643043	Attenuation of morphine analgesic tolerance by rosuvastatin in naïve and morphine tolerance rats
Q89620715	Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy
Q38313076	Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin.
Q84233288	Current literature in diabetes
Q34482501	Discovery and evaluation of novel anti-inflammatory derivatives of natural bioactive curcumin
Q38976172	Effect of ezetimibe on plasma adipokines: a systematic review and meta-analysis.
Q37831911	Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus
Q35101262	Effects of improving glycemic control with insulin on leptin, adiponectin, ghrelin and neuropeptidey levels in patients with type 2 diabetes mellitus: a pilot study
Q36306780	Effects of simvastatin on serum adiponectin: a meta-analysis of randomized controlled trials
Q34461505	Effects of simvastatin treatment on serum adiponectin concentrations in patients with dislipidemia
Q33723646	High-sensitivity C-reactive protein and interleukin-6-dominant inflammation and ischemic stroke risk: the northern Manhattan study
Q36180464	Improved Metabolic Control in Diabetes, HSP60, and Proinflammatory Mediators
Q35830997	Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease.
Q37011168	Simvastatin Treatment Does Not Affect Serum Vitamin D Concentrations in Patients with Dyslipidemia: A Randomized Double-blind Placebo-controlled Cross-over Trial
Q49413115	Statins decrease leptin expression in human white adipocytes
Q42863514	Synthesis and anti-inflammatory evaluation of novel mono-carbonyl analogues of curcumin in LPS-stimulated RAW 264.7 macrophages
Q33748995	The effects of the mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial
Q33742998	Type 2 Diabetes in Young Females Results in Increased Serum Amyloid A and Changes to Features of High Density Lipoproteins in Both HDL2 and HDL3.